Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Genitourinary 6Other hematologic neoplasm 5Lymphoid 5Other 3Gastrointestinal 2Dermatologic 2Thoracic 1Plasma cell 1

Conditions

Melanoma, Cutaneous Malignant 1Melanoma 1

Interventions

Ipilimumab 101pembrolizumab 94Nivolumab 87Cyclophosphamide 69fludarabine phosphate 55aldesleukin 52Interleukin-2 39Dacarbazine 35Vemurafenib 31fludarabine 30trametinib 29dabrafenib 29Temozolomide 28Whole-Body Irradiation 21Aminolevulinic Acid 21Carboplatin 20CTLA-4 Antigen 20Bevacizumab 20Radiotherapy 19Peripheral Blood Stem Cell Transplantation 19Radiosurgery 18Tacrolimus 17Mycophenolic Acid 17Paclitaxel 16HhAntag691 163-ingenyl angelate 16Busulfan 15Introns 14Antilymphocyte Serum 14encorafenib 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Vitamin D × Dermatologic × Clear all
NCT01748448 2025-02-17

ViDMe

Universitaire Ziekenhuizen KU Leuven

Phase 3 Completed
436 enrolled 16 charts
Dermatologic

Melanoma, Cutaneous Malignant

NCT01477463 2016-12-23

Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers

Stanford University

Phase NA Completed
24 enrolled 7 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡